AstraZeneca lifts full-year outlook on upbeat demand for therapies By Reuters
(Reuters) -Anglo-Swedish drugmaker AstraZeneca (NASDAQ:) on Thursday raised its sales and profit forecast for 2024 and topped analyst expectations for...
(Reuters) -Anglo-Swedish drugmaker AstraZeneca (NASDAQ:) on Thursday raised its sales and profit forecast for 2024 and topped analyst expectations for...
Marcus Lindstrom One apartment REIT after another beat on 1Q24 earnings which was surprising as the sector is undergoing a...
Democratic Illinois Gov. JB Pritzker, a vocal supporter of President Biden, was caught on a hot mic Wednesday expressing his...
Morsa Images/DigitalVision via Getty ImagesInvestment action I recommended a buy rating for Progyny, Inc. (NASDAQ:PGNY) when I wrote about it...
winhorse/iStock Unreleased via Getty Images Elevator Pitch I rate Rakuten Group, Inc. (OTCPK:RKUNY) (OTCPK:RKUNF) stock as a Hold. Previously, I...